Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The evaluated claims (opioid co-use fatal CNS/respiratory depression risk, abuse/misuse/addiction leading to overdose/death, and life-threatening withdrawal risk with abrupt cessation/rapid reduction requiring gradual taper) are explicitly supported by the provided Xanax XR label excerpts (5.1, 7.1, 17; 5.2, 17; 5.3, 2.2, 17).
Category Scores
Accurate Statements
Concomitant use with opioids can cause profound sedation, respiratory depression, coma, and death.
Supported by provided excerpts: Risks from Concomitant Use with Opioids (5.1), Drugs Having Clinically Important Interactions with XANAX XR (7.1), and Patient Counseling Information (17).
Benzodiazepines including Xanax XR have risks of abuse/misuse/addiction that can lead to overdose/death.
Supported by provided excerpts: Abuse, Misuse, and Addiction (5.2) and Patient Counseling Information (17).
Abrupt discontinuation or rapid dosage reduction can precipitate life-threatening withdrawal reactions (e.g., seizures) requiring gradual tapering.
Supported by provided excerpts: Dependence and Withdrawal Reactions (5.3), Discontinuation or Dosage Reduction (2.2), and Patient Counseling Information (17).
Unsupported Statements
Contradictions
Important Omissions
Boxed warning presence/wording was mentioned in the user's label assessment text, but the provided excerpts in the prompt were not sufficient to explicitly verify boxed-warning status/labeling as a boxed warning within the evaluation scope.
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
The evaluated statements align with serious, on-label safety warnings (opioid co-use risks, abuse/misuse risk, and withdrawal/tapering risk). No contradictions or unsupported claims were made relative to the provided label excerpts.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Boxed-warning verification was not directly established from the provided excerpt text beyond the general safety-section citations.
Suggested Improvement
If boxed-warning wording/status is to be asserted, include the specific boxed-warning excerpt text from the prescribing information.